Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2023 / Articles / May / Clever Chemistry and Cages
Discovery & Development Drug Delivery Formulation Small Molecules Formulation Small Molecules

Clever Chemistry and Cages

How self-assembling “super-sized” nanocages could encapsulate and deliver drugs to specific targets in the body

By Jamie Irvine 05/19/2023 3 min read

Share

Inspired by natural biological encapsulants, researchers from the University of Cambridge, UK, have created what could be described as “super-sized nanocages,” which can help deliver drug cargoes (1). Using chemical self-assembly to create complex structures with targeted functions from simple building blocks, the research mimics the way viruses build increasingly larger capsids with icosahedral symmetry and quasi-equivalence principles. With more research, these findings could feed into a new wave of drug development. We spoke to Jonathan Nitschke at the University of Cambridge (and recipient of the Izatt-Christensen Award in Supramolecular chemistry in 2022), and first author, Kai Wu, a postdoctoral researcher in the Nitschke lab in the Yusuf Hamied Department of Chemistry, to learn more.

Give us an overview of your research…
 

Our work deals with the preparation of complex structures using a process we refer to as subcomponent self-assembly, where both covalent (generally C=N) and coordinative (N→metal) bonds are formed during the same overall self-assembly process. 

By studying new metal-organic architectures, specifically those that possess intricate structures, we aim to establish design principles that can be used for various application-driven research areas, including phase transfer, host–guest chemistry, and materials science projects.

For many years, we have attempted to create fivefold linking subcomponents based on different backbones for the construction of large capsules using subcomponent self-assembly. These attempts were unsuccessful, either due to the difficulties in subcomponent synthesis or the formation of entropically favored smaller assemblies (for example, sandwich structures). However, with perseverance and additional expertise, we were finally able to tackle this very challenging issue.

Please share some details of your recent success…
 

Our paper, published in Nature Synthesis, describes the development of a novel synthetic strategy for the assembly of progressively larger nanocages using a single pentagonal pyrrole-based subcomponent. The inspiration behind this project came from the natural systems of biological encapsulants, such as viral capsids and ferritin protein cages, which use many identical subunits to tile the surface of a polyhedron. We then sought to understand the construction principles for larger and more functional capsules capable of binding and carrying large biomolecules as cargoes.

After constructing nanocages of increasing size derived from our pyrrole-based subcomponent, we identified the key dihedral angle between the pentagonal faces of the cage. Our results showed that reasoned shifts in the preferred coordination number of the metal ions employed, along with the denticity and steric hindrance of the ligands enabled the generation of progressively larger cages. Ultimately, this provides insight into rational control over the self-assembly of discrete, nanometre-scale, hollow coordination cages composed of simple components.

How could this research support drug discovery and development?
 

Our research could support the future of drug discovery and development by providing a new method for the synthesis of large, self-assembling nanocages that could be used to encapsulate and deliver drugs to specific targets in the body. These nanocages could provide a way to protect and transport biomolecules, including therapeutic agents, to target tissues or cells, enhancing their efficacy while minimizing unwanted side effects. Moreover, the phenomenon of solvent-determined supramolecular transition, which dynamically changes the size of the molecular cage cavity through solvent modulation, holds promise for dynamic encapsulation and release of drug molecules. This work, sponsored in part by Astex Pharmaceuticals under its Sustaining Innovation Postdoctoral Programme, aims to have real-world impact in the field of new drug development.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. K Wu, J Nitschke et. al., “Systematic construction of progressively larger capsules from a fivefold linking pyrrole-based subcomponent,” Nature Synthesis (2023).  DOI: 10.1038/s44160-023-00276-9. www.nature.com/articles/s44160-023-00276-9

About the Author(s)

Jamie Irvine

Associate Editor, The Medicine Maker

More Articles by Jamie Irvine

False

Advertisement

Recommended

False

Related Content

Managing Change in Devices for Patients
Drug Delivery
Managing Change in Devices for Patients

June 21, 2024

4 min read

We need to step away from assumptions on device interchangeability and find out what patients really want

Dosing to Circadian Rhythm
Drug Delivery
Dosing to Circadian Rhythm

December 1, 2014

0 min read

Could medicines be made more effective with better timing?

Connecting the Dots in Drug Delivery
Drug Delivery
Connecting the Dots in Drug Delivery

December 1, 2014

0 min read

The days of “low-hanging fruit” in drug discovery are a thing of the past...

Squid-Inspired Drug Delivery
Drug Delivery Dosage Forms Formulation
Squid-Inspired Drug Delivery

April 3, 2025

4 min read

Here’s how researchers took lessons from cephalopods to develop a new capsule that can deliver drugs, including insulin and siRNA, orally

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.